First-in-human Study of S-588210 (S-488210+S-488211)

NCT04316689 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Lung Cancer
Head and Neck Cancer
Bladder Cancer
Esophageal Cancer
Mesothelioma

Interventions

BIOLOGICAL: S-488210
BIOLOGICAL: S-488211

Sponsor

Shionogi